Canlyniadau Chwilio - Francesco Di Raimondo

Mireinio'r Canlyniadau
  1. 1
    Management of Chronic Myeloid Leukemia in Advanced Phase

    Management of Chronic Myeloid Leukemia in Advanced Phase gan Massimiliano Bonifacio, Fabio Stagno, Luigi Scaffidi, Mauro Krampera, Francesco Di Raimondo

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs

    Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs gan Stefania Stella, Elena Tirrò, Enrico Conte, Fabio Stagno, Francesco Di Raimondo, Livia Manzella, Paolo Vigneri

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Immunological Dysregulation in Multiple Myeloma Microenvironment

    Immunological Dysregulation in Multiple Myeloma Microenvironment gan Alessandra Romano, Concetta Conticello, Maide Cavalli, Calogero Vetro, Alessia La Fauci, Nunziatina Laura Parrinello, Francesco Di Raimondo

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell Biology

    Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell Biology gan Grazia Scuderi, Katia Mangano, Maria Cristina Petralia, Maria Sofia Basile, Francesco Di Raimondo, Paolo Fagone, Ferdinando Nicoletti

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia

    Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia gan Marco Montillo, Alessandra Tedeschi, Susan O’Brien, Francesco Di Raimondo, Susan Lerner, Alessandra Ferrajoli, Enrica Morra, Michael J. Keating

    Cyhoeddwyd 2002
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells

    Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells gan Daniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, Luca Vanella, Concetta Conticello, Alessandra Romano, Salvatore Saccone, Justyna Godos, Francesco Di Raimondo, Giovanni Li Volti

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis

    Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis gan Francesco Di Raimondo, MP Azzaro, Giuseppe A. Palumbo, Sabrina Bagnato, Fabio Stagno, GM Giustolisi, Emma Cacciola, Grazia Sortino, Patrizia Guglielmo, Rosario Giustolisi

    Cyhoeddwyd 2001
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future

    Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future gan Andrea Duminuco, Antonella Nardo, Gaetano Giuffrida, Salvatore Leotta, Uroš Markovic, Cesarina Giallongo, Daniele Tibullo, Alessandra Romano, Francesco Di Raimondo, Giuseppe A. Palumbo

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapy

    Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapy gan Raffaele Palmieri, Anna Candoni, Francesco Di Raimondo, Giuseppe Rossi, Massimo Breccia, Fabrizio Pane, Paola Volpicelli, Benedetta Neri, Paola Finsinger, Morena Caira, Felicetto Ferrara

    Cyhoeddwyd 2025
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia

    Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia gan Michele Massimino, Stefania Stella, Elena Tirrò, Chiara Romano, Maria Stella Pennisi, Adriana Puma, Livia Manzella, Antonio Zanghì, Fabio Stagno, Francesco Di Raimondo, Paolo Vigneri

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents

    Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents gan Alessandra Romano, Nunziatina Laura Parrinello, Marzia L Consoli, Luigi Marchionni, Stefano Forte, Concetta Conticello, Alessandra Pompa, Alessandro Corso, Giuseppe Milone, Francesco Di Raimondo, Ivan Borrello

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy

    Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy gan Alessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, Stefano Forte, Annalisa Chiarenza, Amalia Figuera, Giovanna Motta, Giuseppe A. Palumbo, Massimo Ippolito, Ugo Consoli, Francesco Di Raimondo

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview

    Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview gan Alessandro Barbato, Grazia Scandura, Fabrizio Puglisi, Daniela Cambria, Enrico La Spina, Giuseppe A. Palumbo, Giacomo Lazzarino, Daniele Tibullo, Francesco Di Raimondo, Cesarina Giallongo, Alessandra Romano

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an <i>ad hoc</i> expert panel

    Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an <i>ad hoc</i>... gan Valerio De Stefano, Alessandra Larocca, Monica Carpenedo, Michèle Cavo, Francesco Di Raimondo, Anna Falanga, Massimo Offidani, Maria Teresa Petrucci, Marco Ruggeri, Roberto Santi, Giovanni Barosi

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients

    Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients gan Cesarina Giallongo, Nunziatina Laura Parrinello, Daniele Tibullo, Piera La Cava, Alessandra Romano, Annalisa Chiarenza, Ignazio Barbagallo, Giuseppe A. Palumbo, Fabio Stagno, Paolo Vigneri, Francesco Di Raimondo

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Gene Expression Profiling of Hairy Cell Leukemia Reveals a Phenotype Related to Memory B Cells with Altered Expression of Chemokine and Adhesion Receptors

    Gene Expression Profiling of Hairy Cell Leukemia Reveals a Phenotype Related to Memory B Cells with Altered Expression of Chemokine and Adhesion Receptors gan Katia Basso, Arcangelo Liso, Enrico Tiacci, Roberta Benedetti, Alessandro Pulsoni, Robin Foà, Francesco Di Raimondo, Achille Ambrosetti, Andrea Califano, Ulf Klein, Riccardo Dalla Favera, Brunangelo Falini

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine

    Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccin... gan Giuseppe A. Palumbo, Daniela Cambria, Enrico La Spina, Andrea Duminuco, Antonio Laneri, Anna Longo, Calogero Vetro, Sebastiano Giallongo, Alessandra Romano, Francesco Di Raimondo, Daniele Tibullo, Cesarina Giallongo

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival

    Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival gan Alessia Ongaro, Monica De Mattei, Matteo Giovanni Della Porta, Gian Matteo Rigolin, C Ambrósio, Francesco Di Raimondo, Agnese Pellati, Federica Francesca Masieri, Angelo Caruso, L. Catozzi, Donato Gemmati

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience

    Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience gan Andrea Duminuco, Anna Bulla, Rosamaria Rosso, M. A. Romeo, Daniela Cambria, Enrico La Spina, Benedetta Ximenes, Cesarina Giallongo, Daniele Tibullo, Alessandra Romano, Francesco Di Raimondo, Giuseppe A. Palumbo

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Monocytic myeloid‐derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib

    Monocytic myeloid‐derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib gan Cesarina Giallongo, Nunziatina Laura Parrinello, Piera La Cava, Giuseppina Camiolo, Alessandra Romano, Marina Scalia, Fabio Stagno, Giuseppe A. Palumbo, Roberto Avola, Giovanni Li Volti, Daniele Tibullo, Francesco Di Raimondo

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: